Anti-cyclic citrullinated peptide (anti-CCP) antibodies with brucellosis

Bunyamin Kisacik; Muhammet Said Dag; Yavuz Pehlivan; Kenan Ugurlu; Ozge Kaya Mercan; Musa Aydinli; Seda Duygulu Devay; Mehmet Sayarlioglu; Ahmet Mesut Onat

doi:10.1007/s00296-013-2777-1

Anti-cyclic citrullinated peptide (anti-CCP) antibodies with brucellosis

Rheumatol Int. 2014 Jun;34(6):873-4. doi: 10.1007/s00296-013-2777-1. Epub 2013 May 18.

Authors

Bunyamin Kisacik¹, Muhammet Said Dag, Yavuz Pehlivan, Kenan Ugurlu, Ozge Kaya Mercan, Musa Aydinli, Seda Duygulu Devay, Mehmet Sayarlioglu, Ahmet Mesut Onat

Affiliation

¹ Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Gaziantep University, Şahinbey, 27100, Gaziantep, Turkey, [email protected].

PMID: 23686219
DOI: 10.1007/s00296-013-2777-1

Abstract

Anti-cyclic citrullinated peptide (anti-CCP) was positive in 11.5 % and rheumatoid factor was positive in 8.8 % of the patients with Brucella. After a comparative evaluation, we have found out that there was not a statistical significance concerning the anti-CCP levels between the patients with brucellosis and healthy control.

Publication types

Letter

MeSH terms

Adult
Arthritis, Rheumatoid / immunology*
Autoantibodies / immunology*
Brucellosis / immunology*
Case-Control Studies
Female
Humans
Male
Middle Aged
Peptides, Cyclic / immunology*
Rheumatoid Factor / immunology
Young Adult

Substances

Autoantibodies
Peptides, Cyclic
cyclic citrullinated peptide
Rheumatoid Factor